Delivery Order SPE2DB22D2206-SPE2DB25FKC84
Award Date 9/25/25
Potential Completion Date 9/26/25
Potential Value $31K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product valued at $20,952.85. This firm fixed-price delivery order, which has an ultimate completion date of September 12, 2025, represents a competitive award with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,381.44 to AmerisourceBergen Drug Corp for the supply of Cefepime-Dextrose 2 GM/50 MLS, a broad-spectrum antibiotic commonly used in acute care settings. The contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and represents a firm fixed price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,565.69 to AmerisourceBergen Drug Corp for the supply of Cefepime-Dextrose 2 GM/50 mLS, an antibiotic medication commonly used in military and federal healthcare systems. This firm fixed-price delivery order, issued on August 13, 2025, was competitively awarded with no set-aside designation and is scheduled for completion by August 14, 2025. The product will be performed and delivered from AmerisourceBergen's Corporate...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,171,074 units of the pharmaceutical product Cefepime-Dextrose 2 GM/50 MLS. The contract has a ceiling value of $3,653.65 and an ultimate completion date of April 5, 2024. This delivery order contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds...
- The Defense Logistics Agency awarded a delivery order valued at $3,318.31 to AmerisourceBergen Drug Corp for the supply of Cefepime-Dextrose 2 GM/50 MLS, an antibiotic pharmaceutical product. This non-set-aside, firm fixed price delivery order was awarded on July 27, 2025, with a completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $2,620.75 delivery order to AmerisourceBergen Drug Corp for Cefepime-Dextrose 2 gm/50 mls, an antibiotic solution used in military and federal healthcare settings. This firm fixed price contract, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a competitive award with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,776.68 to AmerisourceBergen Drug Corp for Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product for military medical supply needs. This firm fixed price delivery order, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside and will be performed in Conshohocken, Pennsylvania, where the contractor maintains its corporate headquarters. Cefepime is a fourth-generation cephalosporin antibiotic...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 4, 2025, by the Defense Logistics Agency (DLA) for the supply of Cefepime-Dextrose 2 GM/50 MLS. This competitively awarded, firm fixed-price delivery order is valued at $12,695.91 and carries an ultimate completion date of September 5, 2025. The product will be delivered to the Conshohocken, PA location. As a child contract under a larger vehicle,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,717.32, is for the delivery of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product, with a performance period ending on January 25, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $14,903.68 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of 4564015152 CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and...